Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1995-05-17
1997-07-29
Azpuru, Carlos
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
424464, 424465, 424468, 514 58, 514777, 514778, A61K 920, A61K 922, A61K 31715, A61K 4740
Patent
active
056519834
ABSTRACT:
The present invention relates to a pharmaceutical composition in a unit dosage form for peroral administration in a human or lower animal, having a gastrointestinal tract comprising a small intestine and a colon with a lumen therethrough having an inlet to the colon from the small intestine, comprising:
REFERENCES:
patent: 2764590 (1956-09-01), Kottler et al.
patent: 3431338 (1969-03-01), Munzel
patent: 4432966 (1984-02-01), Zeitoun et al.
patent: 4816259 (1989-03-01), Matthews et al.
patent: 4822629 (1989-04-01), Pong
patent: 4834985 (1989-05-01), Elger et al.
patent: 4910021 (1990-03-01), Davis et al.
patent: 4952402 (1990-08-01), Sparks et al.
patent: 5068110 (1991-11-01), Fawzi et al.
patent: 5171580 (1992-12-01), Iamartino et al.
patent: 5283064 (1994-02-01), Suzuki et al.
patent: 5330759 (1994-07-01), Pagay et al.
Schmidt, P.C., "The MiniWiD-Coater: II. Comparison of Acid Resistance of Enteric-Coated Bisacodyl Pellets Coated With Different Polymers," Drug Development & Industrial Pharmacy, vol. 18, No. 18 (1992), pp. 1969-1979.
Luce, G.T., "Disintegration of tablets enteric coated with cellulose acetate phthalate," Pharm. Tech., vol. 2 (Oct. 1978), pp. 51-55.
Spitael, J., et al. "Enteric Coating using cellulose acetate phthalate", Manuf. Chem., vol. 57, No. 8 (Aug. 1986), pp. 35, 37.
Kane, Y. et al. "Technological evaluation of three enteric coating polymers. Part I. With an insoluble drug," Drug Dev. Ind. Pharm., vol. 19, No. 16 (1993), pp. 2011-2020.
Luce, G.T., "Disintegration of tablets enteric coated with CAP (cellulose acetate phthalate)," Manuf. Chem. Aerosol News, vol. 49, No. 50 (1978), pp. 50, 52, 67.
Preston, D.M., "Pelvic Motility and Response to Intraluminal Bisacodyl in Slow-Transit Constipation," Digestive Diseases & Sciences, vol. 30, No. 4 (1985), pp. 289-294.
Kamm, M.A. et al., "Dynamic scanning defines a colonic defect in severe idiopathic constipation," Gut, vol. 29 (1988), pp. 1085-1092.
Jauch, R. et al., "Bis-(p-hydroxyphenyl)-pyridyl-2-methane: The Common Laxative Principle of Bisacodyl and Sodium Picosulfate," Arzneim.-Forsch. (Drug Res.), vol. 25, No. 11 (1975), pp. 1796-1800.
Roth, W., "Translation of Pharmacokinetics and Laxative Effect of Bisacodyl After Administration of Various Dosage Forms," Arzneim.-Forsch./Drug Res., vol. 38(1), No. 4 (1988), pp. 570-574.
Leng-Peschlow, E., "Effects of Sennosides A +B and Bisacodyl on Rat Large Intestine," Pharmacology, vol. 38 (1989), pp. 310-318.
Rasmussen, S., "Intestinal Absorption of Quinine from Enteric Coated Tablets," Acta Pharmacol. et Toxicol vol. 24 (1966) pp. 331-345.
Davis Paula Denise
Dobrozsi Douglas Joseph
Kelm Gary Robert
Mandel Kenneth Gary
Manring Gary Lee
Azpuru Carlos
The Procter & Gamble & Company
Zea Betty J.
LandOfFree
Bisacodyl dosage form for colonic delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bisacodyl dosage form for colonic delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisacodyl dosage form for colonic delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-631787